To access this element change to forms mode OFF
Grant Award View - GA60393
A novel platform for large-scale production of a first-in-class biologic...
GA ID:
GA60393
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
1-Aug-2019
Publish Date:
4-Nov-2019
Category:
Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2022
Value (AUD):
$658,135.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Development Grants
Grant Activity:
A novel platform for large-scale production of a first-in-class biologic drug for stroke
Purpose:
Stroke is the second leading cause of death worldwide and the primary cause of long-term disability, incurring healthcare costs of almost $200B per annum. In this project we will develop a novel algal production platform for manufacturing a biologic drug (Hi1a) we recently discovered that prevents brain damage even when delivered up to 8 hours after the onset of stroke. This project will enable large-scale production of Hi1a for human clinical trials.
GO ID:
GO Title:
NHMRC Development Grants 2019 for funding in 2020
Internal Reference ID:
GNT1176216
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Queensland
Recipient ABN:
63 942 912 684
Grant Recipient Location
Suburb:
St Lucia
Town/City:
St Lucia
Postcode:
4072
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
QLD
Postcode:
Country:
AUSTRALIA